The testosterone courses are at the forefront of a resurgence in industry-funded continuing medical education courses, often offered for free to doctors who need the credits to maintain their medical licenses, a Milwaukee Journal Sentinel/MedPage Today investigation found.
The funding dropped temporarily after congressional investigations showed drug companies had manipulated such programs to market unapproved uses for their products. But income for the courses rebounded to a near-record $2.7 billion last year.
Read Full Article »